Physician profile
Michael Cody Curry
NPI 1144515016
$11,228.76
in general payments reported to CMS, 2019-2025
17 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $384 · 2021: $735 · 2022: $6,222 · 2023: $85.86 · 2024: $480 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,162 · Travel and Lodging: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.79 |
| Travel and Lodging | $438.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,230.50 | 2019-2025 | |
| Arthrex, INC. | $4,098.49 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $824.02 | 2019-2022 | |
| Depuy Synthes Sales INC. | $620.37 | 2020-2025 | Na, Quickanchor Orthocord, Healix Knotless Peek |
| Medical Device Business Services, INC. | $398.46 | 2021 | |
| Stryker Corporation | $236.97 | 2022 | |
| Anika Therapeutics, INC. | $165.78 | 2025 | Integrity Implant |
| Restor3d, INC. | $143.88 | 2024 | |
| Medtronic, INC. | $143.57 | 2021 | |
| Bioventus LLC | $80.07 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $66.53 | 2023-2025 | Iovera, Zilretta, Exparel |
| Ethicon US, LLC | $65.00 | 2025 | Stratafix, Vistaseal |
| Vertex Pharmaceuticals Incorporated | $55.52 | 2025 | |
| Smith+Nephew, INC. | $38.64 | 2019-2022 | |
| Galderma Laboratories, L.P. | $33.23 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $15.27 | 2024 | Dynasplint |
| Melinta Therapeutics, LLC | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Curry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.